A novel transcript encoded within the 10-kb first intron of the human p53 tumor suppressor gene (D17S2179E) is induced during differentiation of myeloid leukemia cells

Genomics

Volumn 38, Issue 3, 1996, Pages 364-370

  Reisman, David ^a   Bálint, Éva ^a   Loging, W Troy ^a   Rotter, Varda ^b   Almon, Einat ^b,c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA BINDING PROTEIN; MESSENGER RNA; POLYADENYLATED RNA; PROTEIN P53;

ARTICLE; CELL DIFFERENTIATION; DNA LIBRARY; DNA SEQUENCE; HUMAN; HUMAN CELL; INTRON; LEUKEMIA CELL LINE; MOLECULAR CLONING; MYELOID LEUKEMIA; OPEN READING FRAME; PRIORITY JOURNAL; PSEUDOGENE; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; STOP CODON; TUMOR SUPPRESSOR GENE;

EID: 0030589640     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0639     Document Type: Article

References (35)

1. Aloni-Grinstein, R., Schwartz, D., and Rotter, V. (1995). Accumulation of wild type p53 protein upon γ-irradiation induces a G2-dependent immunoglobulin κ light chain gene expression. EMBO J. 14: 1392-1401.
2. Brockdorff, N., Ashworth, A., Kay, G. F., McCabe, V. M., Norris, D. P., Cooper, P. J., Swift, S., and Rastan, S. (1992). The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71: 515-526.
3. Chirgwin, J. M., Przybla, A. E., MacDonald, R. J., and Rutter, W. J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
4. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. (1993). Thymocyte apoptosis induced by p53 dependent and independent pathways. Nature 362: 849-852.
5. Donehower, L. A., and Bradley, A. (1993). The tumor suppressor p53. Biochim. Biophys. Acta. 1155: 181-205.
6. El-Diery, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. (1992). Definition of a consensus binding site for p53. Nature Genet. 1: 45-49.
7. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
8. Fields, S., and Jang, S. K. (1990). Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1046-1049.
9. Ghosh, S., Gifford, A. M., Riviere, L. R., Tempst, P., Nolan, G. P., and Baltimore, D. (1990). Cloning of the p50 DNA binding subunit of NF-/κB: Homology to rel and dorsal. Cell 62: 1019-1029.
10. Isobe, M., Emanuel, B. S., Givol, D., Oren, M., and Croce, C. M. (1986). Localization of gene for human p53 to band 17p13. Nature 320: 84-85.
11. Kastan, M. B., Onyerkwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 in the cellular response to DNA damage. Cancer Res. 53: 6304-6311.
12. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71: 587-597.
13. Khochbin, S., Principaud, E., Chabanas, A., and Lawrence, J. J. (1988). Early events in murine erythroleukemia cells induced to differentiate. J. Mol. Biol. 200: 55-64.
14. Khochbin, S., and Lawrence, J. J. (1989). An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate. EMBO J. 8: 4107-4114.
15. Kieran, M., Blank, V., Logeat, F., Vandekerchhove, J., Lottspeich, F., Le Bail, O., Urban, M. B., Kourilsky, P., Baeuerle, P.A., and Israël, A. (1990). The DNA binding subunit of NF-/κB is identical to factor KBF1 and is homologous to the rel oncogene product. Cell 62: 1007-1018.
16. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495.
17. Lane, D. (1992). p53: Guardian of the genome. Nature 358: 15-16.
18. Levine, A. J., Perry, M. E., Chang, A., Silver, A., Dittmer, D., and Welsh, D. (1994). The 1993 Walter Hubert Lecture: The role of the p53 tumor suppressor gene in tumorigenesis. Br. J. Cancer 69: 409-416.
19. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. (1992). Altered cell cycle, arrest and gene amplification potential accompany loss of wild type p53. Cell 70: 923-935.
20. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. (1993). p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362: 847-849.
21. Maltzman, W., and Czyzyk, L. (1984). UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed cells. Mol. Cell. Biol. 4: 1689-1694.
22. Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., and Cline, M. J. (1987). Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA 84: 7716-7719.
23. Michalovitz, D., Halevy, O., and Oren, M. (1990). Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680.
24. Miller, C., Mohandas, T., Wolf, D., Prokocimer, M., Rotter, and Koeffler, P. H. (1986). Human p53 localized to short arm of chromosome 17. Nature 319: 783-784.
25. Miyashita, T., and Reed, J. C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
26. Oltivai, Z. N., Milliman, C., and Korsmeyer, S. J. (1993). Bcl-2hetero-dimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
27. Prokocimer, M., and Rotter, V. (1994). Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic lineage. Blood 84: 2391-2411.
28. Raycroft, L., Wu, H., and Lozano, G. (1990). Transcriptional activation by wild type but not by transforming mutants of the p53 anti-oncogene. Science 249: 1049-1051.
29. Reisman, D., Greenberg, M., and Rotter, V. (1988). Human p53 oncogene contains one promoter upstream of exon one and a second stronger promoter within intron one. Proc. Natl. Acad. Sci. USA 85: 5146-5150.
30. Reisman, D., and Rotter, V. (1989). Two promoters that map to the 5′ sequences of the human p53 gene are differentially regulated during terminal differentiation of human myaloid leukemia cells. Oncogene 4: 945-953.
31. Schmid, R. M., Perkins, N. D., Duckett, C. S., Andrews, P. C., and Nabel, G. (1991). Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature 352: 733-736.
32. Smith, M. L., Chen, I. T., Zhan, Q., Bea, I., Chen, C. Y., Gilmer, T., Kastan, M. B., O'Conner, P. M., and Forance, A. J. (1994) Science 266: 1376-1378.
33. Soussi, T., Caron de Fromentel, C., Mechali, M., May, P., and Kress, M. (1987). Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homolgous to human and murine p53. Oncogene 1: 71-78.
34. Wade-Harper, J., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
35. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991). Wild-type p53 induces apoptosis of meloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345-347.